Cidara Therapeutics (CDTX) Other Non Operating Income: 2017-2025
Historic Other Non Operating Income for Cidara Therapeutics (CDTX) over the last 6 years, with Sep 2025 value amounting to $5.4 million.
- Cidara Therapeutics' Other Non Operating Income rose 190.21% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 135.65%. This contributed to the annual value of $5.8 million for FY2024, which is 191.28% up from last year.
- Per Cidara Therapeutics' latest filing, its Other Non Operating Income stood at $5.4 million for Q3 2025, which was up 223.83% from $1.7 million recorded in Q2 2025.
- Cidara Therapeutics' Other Non Operating Income's 5-year high stood at $5.4 million during Q3 2025, with a 5-year trough of -$70,000 in Q1 2021.
- In the last 3 years, Cidara Therapeutics' Other Non Operating Income had a median value of $1.7 million in 2025 and averaged $1.5 million.
- Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 10,483.33% in 2023, then fell by 6.09% in 2025.
- Cidara Therapeutics' Other Non Operating Income (Quarterly) stood at -$33,000 in 2021, then soared by 590.91% to $162,000 in 2022, then soared by 225.31% to $527,000 in 2023, then spiked by 244.02% to $1.8 million in 2024, then soared by 190.21% to $5.4 million in 2025.
- Its Other Non Operating Income stands at $5.4 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.8 million for Q1 2025.